ICL
NYSE · Chemicals
Icl Group Ltd
$6.37
+0.37 (+6.17%)
Financial Highlights (FY 2026)
Revenue
18.31B
Net Income
578.48M
Gross Margin
30.6%
Profit Margin
3.2%
Rev Growth
-10.6%
D/E Ratio
0.46
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 30.6% | 30.6% | 37.4% | 37.4% |
| Operating Margin | 8.1% | 7.3% | 17.6% | 17.0% |
| Profit Margin | 3.2% | 3.0% | 18.0% | 15.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 18.31B | 20.48B | 7.12B | 6.72B |
| Gross Profit | 5.60B | 6.26B | 2.66B | 2.51B |
| Operating Income | 1.48B | 1.50B | 1.25B | 1.14B |
| Net Income | 578.48M | 582.43M | 1.28B | 1.02B |
| Gross Margin | 30.6% | 30.6% | 37.4% | 37.4% |
| Operating Margin | 8.1% | 7.3% | 17.6% | 17.0% |
| Profit Margin | 3.2% | 3.0% | 18.0% | 15.1% |
| Rev Growth | -10.6% | -10.6% | +21.5% | +18.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 3.32B | 3.32B | 3.42B | 3.02B |
| Total Equity | 7.21B | 7.21B | 10.49B | 11.64B |
| D/E Ratio | 0.46 | 0.46 | 0.33 | 0.26 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 2.67B | 2.84B | 1.79B | 1.80B |
| Free Cash Flow | — | — | 781.09M | 495.76M |